Penny Stocks Archives - Page 1155 of 1231

5 minute read

Why Plug Power Is Trading Higher By Around 14%, Here Are 73 Stocks Moving In Wednesday’s Mid-Day Session

August 10, 12:47 PM

Gainers BioAtla, Inc. (NASDAQ: BCAB) gained 50.1% to $5.42 following Q2 results. Euro Tech Holdings Company Limited (NASDAQ: CLWT) surged 39.5% to $2.0380.

ABCL

1 minute read

ReShape Lifesciences Shares Soar As FDA Announced Clearance To GIBI HD Calibration Tubes In Weight Loss Procedures

By Ragothaman Srinivasan

August 10, 12:42 PM

The U.S. Food and Drug Administration (FDA) has announced 510(k) clearance to ReShape Lifesciences’ (NASDAQ: RSLS) Gastro Intestinal Balloon Indicator (GIBI HD) calibration tube for use in gastric and bariatric surgical procedures.

RSLS

3 minute read

4 Silver Stocks Bouncing Off Of Lows

By John Navin

August 10, 12:42 PM

With gold bouncing upward off of its July lows, it’s probably a good time to assess the price movement in its sister metal, silver.

1 minute read

RealReal Gets Downgraded Downgraded: Analyst Slashes Luxury Resale Store’s Rating By Two Notches

By Priya Nigam

August 10, 12:06 PM

Decelerating growth will likely extend RealReal Inc.’s (NASDAQ: REAL) timeline to breakeven, according to Bank of America Securities.

REAL

1 minute read

WeTrade, Roblox And Some Other Big Stocks Moving Lower On Wednesday

By Lisa Levin

August 10, 11:44 AM

OptimizeRx Corporation (NASDAQ: OPRX) shares fell 26.7% to $16.32 after the company reported worse-than-expected Q2 EPS and sales results and issued FY22 sales guidance below estimates.

ALC

1 minute read

Lexaria Gets FDA’s Positive Feedback On Pre-Clinical Trial Of Hypertension Candidate

By Ragothaman Srinivasan

August 10, 11:36 AM

Lexaria Bioscience Corp. (NASDAQ: LEXX) announced that it has received a positive full written response from the Food and Drug Administration (FDA) from its pre-Investigational New Drug meeting regarding DehydraTECH-CBD for the treatment of hypertension.

LEXX

4 minute read

Biotech Daily: Cancer Causing Impurities In Merck’s Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon’s Monkeypox Trial

By Vandana Singh

August 10, 11:33 AM

Here's a roundup of top developments in the biotech space over the last 24 hours:

ADMP

2 minute read

Meet Blue Serenity, Canada’s First Natural Therapeutic Psilocybin Product For Approved Patients

By Lara Goldstein

August 10, 11:26 AM

The Canadian-based company licensed by Health Canada for psychedelic and functional mushrooms production, Optimi Health Corp.

OPTHF

1 minute read

Organogenesis’ Q2 Operating Income Fell 50%, Lowers Annual Guidance

By Vandana Singh

August 10, 11:10 AM

Organogenesis Holdings Inc’s (NASDAQ:ORGO) Q2 FY22 sales reached $121.4 million, down 1% Y/Y, slightly ahead of the consensus of $120.90…

ORGO

1 minute read

Aridis’ Inhaled Pan-Coronavirus Antibody Cocktail Shows Encouraging Preclinical Action

By Vandana Singh

August 10, 10:40 AM

Aridis Pharmaceuticals Inc’s (NASDAQ:ARDS) inhaled treatment of its fully human monoclonal antibody cocktail AR-701 resulted in no detectable SARS-CoV-2 virus in…

ARDS